Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
algorithmic components and primarily programming courses with a focus on bioinformatics methods. Such graduate courses seek experienced bioinformatics, biotech, and data science professionals with a desire to
-
Employer, Title IX University. All qualified applicants will receive consideration for employment without regard to race, color, religion, religious creed, genetic information, sex, gender, gender identity
-
, color, religion, religious creed, genetic information, sex, gender, gender identity, sexual orientation, age, national origin, ancestry, veteran or disability status, or any other characteristic protected
-
qualified applicants will receive consideration for employment without regard to race, color, religion, religious creed, genetic information, sex, gender, gender identity, sexual orientation, age, national
-
Educational Institution and Employer, Title IX University. All qualified applicants will receive consideration for employment without regard to race, color, religion, religious creed, genetic information, sex
-
for employment without regard to race, color, religion, religious creed, genetic information, sex, gender, gender identity, sexual orientation, age, national origin, ancestry, veteran or disability status, or any
-
About the Opportunity ABOUT THE OPPORTUNITY The Di Pierro Lab is focused primarily on physical genetics. We are broadly interested in the physical processes involved in the translation of genetic
-
for employment without regard to race, color, religion, religious creed, genetic information, sex, gender, gender identity, sexual orientation, age, national origin, ancestry, veteran or disability status, or any
-
diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause
-
diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause